Could this startup's compact nuclear reactors revolutionize cancer detection?
Summary
Now, a startup from Bristol, U.K. hopes to ramp up production of these materials by using a new, radical, technology.Astral Systems, co-founded by Talmon Firestone and Dr. Tom Wallace-Smith, employs something called multistate fusion (MSF) technology in its compact reactors, enabling the increased supply of the nuclear isotopes used in modern medicine. These reactors are in fact so compact that they can fit on the average desk.Astral has now closed over \xa34.5 million investment led by Austria-based VC Speedinvest and U.K.-based Playfair.The company says its approach will commercialize MSF technology, achieving better performance with greater efficiency and lower cost than traditional reactors.The approach employs so-called lattice confinement fusion (LCF), a concept first discovered by NASA. We can then produce the drugs exactly where they needed, and be able to reduce the reliance on these centralized production sites, he added.He believes competitors are constrained by existing technology: Most other approaches are based on linear, accelerated technology, whereas what were doing is essentially taking a very high TRL core architecture and putting in 2020 physics, where the ceiling is quite high in terms of performance. So were just at the start of whats achievable with this, he said.In a statement, Rick Hao, partner at Speedinvest added: Astral Systems represents the best of UK deeptech. Astral is delivering a fresh approach to nuclear fusion that addresses urgent medical, industrial and power needs.So far Astral has established three commercial fusion facilities from which its already generating revenues.Also participating in the round was participation of angel investors including Oliver Buck, founder of ITM Isotope Technologies, and former ARM president of Product Group, Pete Hutton.